Antimicrobial-resistant Shigella: where do we go next?

Shigella spp. that are resistant to almost all antimicrobial classes are increasing in prevalence and becoming globally dominant. The situation is critical and highlights a trend that is mirrored by other enteric bacterial pathogens. New interventions to prevent and treat these infections are essent...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Stephen, Scott, Timothy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184058/
https://www.ncbi.nlm.nih.gov/pubmed/37188805
http://dx.doi.org/10.1038/s41579-023-00906-1
_version_ 1785042088709062656
author Baker, Stephen
Scott, Timothy A.
author_facet Baker, Stephen
Scott, Timothy A.
author_sort Baker, Stephen
collection PubMed
description Shigella spp. that are resistant to almost all antimicrobial classes are increasing in prevalence and becoming globally dominant. The situation is critical and highlights a trend that is mirrored by other enteric bacterial pathogens. New interventions to prevent and treat these infections are essential to tackle a potential public health catastrophe.
format Online
Article
Text
id pubmed-10184058
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-101840582023-05-16 Antimicrobial-resistant Shigella: where do we go next? Baker, Stephen Scott, Timothy A. Nat Rev Microbiol Comment Shigella spp. that are resistant to almost all antimicrobial classes are increasing in prevalence and becoming globally dominant. The situation is critical and highlights a trend that is mirrored by other enteric bacterial pathogens. New interventions to prevent and treat these infections are essential to tackle a potential public health catastrophe. Nature Publishing Group UK 2023-05-15 2023 /pmc/articles/PMC10184058/ /pubmed/37188805 http://dx.doi.org/10.1038/s41579-023-00906-1 Text en © Springer Nature Limited 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Baker, Stephen
Scott, Timothy A.
Antimicrobial-resistant Shigella: where do we go next?
title Antimicrobial-resistant Shigella: where do we go next?
title_full Antimicrobial-resistant Shigella: where do we go next?
title_fullStr Antimicrobial-resistant Shigella: where do we go next?
title_full_unstemmed Antimicrobial-resistant Shigella: where do we go next?
title_short Antimicrobial-resistant Shigella: where do we go next?
title_sort antimicrobial-resistant shigella: where do we go next?
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184058/
https://www.ncbi.nlm.nih.gov/pubmed/37188805
http://dx.doi.org/10.1038/s41579-023-00906-1
work_keys_str_mv AT bakerstephen antimicrobialresistantshigellawheredowegonext
AT scotttimothya antimicrobialresistantshigellawheredowegonext

Ejemplares similares